Sarepta Therapeutics to Announce Third Quarter 2017 Financial Results and Recent Corporate Developments on October 25, 2017
October 16 2017 - 8:30AM
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage
biopharmaceutical company focused on the discovery and development
of precision genetic medicines to treat rare neuromuscular
diseases, will report third quarter 2017 financial results after
the Nasdaq Global Market closes on Wednesday, October 25, 2017.
Subsequently, at 4:30 p.m. Eastern Time, the Company will host a
conference call to discuss its third quarter 2017 financial results
and to provide a corporate update.
The conference call may be accessed by dialing 844-534-7313 for
domestic callers and +1-574-990-1451 for international callers. The
passcode for the call is 1598174. Please specify to the operator
that you would like to join the "Sarepta Third Quarter 2017
Earnings Call". The conference call will be webcast live under the
investor relations section of Sarepta's website at www.sarepta.com
and will be archived there following the call for 90 days. Please
connect to Sarepta's website several minutes prior to the start of
the broadcast to ensure adequate time for any software download
that may be necessary.
About Sarepta Therapeutics
Sarepta Therapeutics is a commercial-stage biopharmaceutical
company focused on the discovery and development of precision
genetic medicines to treat rare neuromuscular diseases. The Company
is primarily focused on rapidly advancing the development of its
potentially disease-modifying Duchenne muscular dystrophy (DMD)
drug candidates. For more information, please visit
www.sarepta.com.
Internet Posting of Information
We routinely post information that may be important to investors
in the 'For Investors' section of our website
at www.sarepta.com. We encourage investors and potential
investors to consult our website regularly for important
information about us.
Source: Sarepta Therapeutics, Inc.
Media and Investors: Sarepta Therapeutics, Inc. Ian Estepan,
617-274-4052 iestepan@sarepta.com or W2O Group Brian Reid,
212-257-6725 breid@w2ogroup.com
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sarepta Therapeutics (NASDAQ:SRPT)
Historical Stock Chart
From Apr 2023 to Apr 2024